TOXIC EPIDERMAL NECROLYSES

Clinical trials for TOXIC EPIDERMAL NECROLYSES explained in plain language.

Never miss a new study

Get alerted when new TOXIC EPIDERMAL NECROLYSES trials appear

Sign up with your email to follow new studies for TOXIC EPIDERMAL NECROLYSES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Breakthrough trial aims to tame deadly Skin-Shedding reaction

Disease control Completed

This study tested whether a drug called etanercept could help patients with severe, life-threatening skin reactions (SJS/TEN) heal faster. It compared etanercept against the current standard of supportive care alone. The main goal was to see which approach led to the quickest com…

Matched conditions: TOXIC EPIDERMAL NECROLYSES

Phase: PHASE3 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

TOXIC EPIDERMAL NECROLYSES

Get alerted when new TOXIC EPIDERMAL NECROLYSES trials appear

Breakthrough trial aims to tame deadly Skin-Shedding reaction